IndiaTickerStrides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeBSE · conference call · pdf
Source filing Company dossier
Strides Pharma Science
NSE:STAR · ISIN INE939A01011
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Strides Pharma Science
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome — recordingBSE · conference call recording · pdf
Source filing Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeBSE · conference call · pdf
Source filing Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome — recordingBSE · conference call recording · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Strides Pharma Science LimitedNSE · conference call · pdf
Source filing Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Investor PresentationBSE · investor presentation · pdf
Source filing Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Press Release - Strides Pharma Science LimitedNSE · exchange filing · pdf
Source filing General Updates - Strides Pharma Science LimitedNSE · investor presentation · pdf
Source filing Strides Pharma Science Ltd - 532531 - Outcome Of Board Meeting Of The Company Held On July 31, 2026BSE · financial results · pdf
Source filing Outcome of Board Meeting - Strides Pharma Science LimitedNSE · financial results · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Strides Pharma Science LimitedNSE · conference call · pdf
Source filing Strides Pharma Science Ltd - 532531 - Board Meeting Intimation for Considering And Approving The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended June 30, 2026, Amongst Other Matters.BSE · financial results · pdf
Source filing Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · conference call · pdf
Source filing Business Responsibility and Sustainability Report FY 2025-2026 - Strides Pharma Science LimitedNSE · business responsibility report · pdf
Source filing Annual Report 2026 - STRIDES PHARMA SCIENCE LIMITEDBSE · annual report · pdf
Archived filing Annual Report FY 2025-2026 - Strides Pharma Science LimitedNSE · annual report · pdf
Source filing Strides Pharma Science Ltd - 532531 - Reg. 34 (1) Annual Report.BSE · annual report · pdf
Archived filing Strides Pharma Science Ltd - 532531 - Business Responsibility and Sustainability Reporting (BRSR)BSE · exchange filing · pdf
Source filing Strides Pharma Science Ltd - 532531 - Notice Of 35Th Annual General MeetingBSE · exchange filing · pdf
Source filing Strides Pharma Science Ltd - 532531 - Notice Of 35Th Annual General MeetingBSE · exchange filing · pdf
Source filing General Updates - Strides Pharma Science LimitedNSE · exchange filing · pdf
Source filing Shareholders meeting - Strides Pharma Science LimitedNSE · exchange filing · pdf
Source filing Strides Pharma Science Ltd - 532531 - Company Has Fixed The Record Date For Final Dividend For FY26 As Friday, July 31, 2026BSE · corporate action · pdf
Source filing Record Date - Strides Pharma Science LimitedNSE · exchange filing · pdf
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Strides Pharma Science LimitedNSE · exchange filing · pdf
Source filing Strides Pharma Science Ltd - 532531 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Sale or disposal - Strides Pharma Science LimitedNSE · exchange filing · pdf
Source filing Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-RestructuringBSE · exchange filing · pdf
Source filing Press Release - Strides Pharma Science LimitedNSE · exchange filing · pdf
Source filing Sale or disposal - Strides Pharma Science LimitedNSE · exchange filing · pdf
Source filing Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-RestructuringBSE · exchange filing · pdf
Source filing Trading Window - Strides Pharma Science LimitedNSE · exchange filing · pdf
Source filing Strides Pharma Science Ltd - 532531 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Strides Pharma Science LimitedNSE · conference call · pdf
Source filing Strides Pharma Science Ltd - 532531 - Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Reminder To Shareholders Regarding Unclaimed Dividends And Transfer To IEPFBSE · corporate action · pdf
Source filing Strides Pharma Science Ltd - 532531 - Intimation Of Effective Date For The Scheme Of Demerger Involving Arco Lab Private Limited ('Arco Lab') And Pivot Path Private Limited ('Pivot Path')BSE · exchange filing · pdf
Source filing